Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Gupta, Sahil
Zivadinov, Robert
Ramanathan, Murali
and
Weinstock-Guttman, Bianca
2016.
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?.
Expert Review of Neurotherapeutics,
Vol. 16,
Issue. 7,
p.
765.
Frezzotti, Paolo
Giorgio, Antonio
Toto, Francesca
De Leucio, Alessandro
and
De Stefano, Nicola
2016.
Early changes of brain connectivity in primary open angle glaucoma.
Human Brain Mapping,
Vol. 37,
Issue. 12,
p.
4581.
De Angelis, Floriana
Plantone, Domenico
and
Chataway, Jeremy
2018.
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.
CNS Drugs,
Vol. 32,
Issue. 6,
p.
499.
Tiwari, Shivani
Sharma, Varsha
Mujawar, Mubarak
Mishra, Yogendra Kumar
Kaushik, Ajeet
and
Ghosal, Anujit
2019.
Biosensors for Epilepsy Management: State-of-Art and Future Aspects.
Sensors,
Vol. 19,
Issue. 7,
p.
1525.
Mezu-Ndubuisi, Olachi J.
Adams, Thao
Taylor, Lauren K.
Nwaba, Adaure
and
Eickhoff, Jens
2019.
Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
Eye,
Vol. 33,
Issue. 3,
p.
363.
Al-Louzi, Omar
Sotirchos, Elias S
Vidal-Jordana, Angela
Beh, Shin C
Button, Julia
Ying, Howard S
Balcer, Laura J
Frohman, Elliot M
Saidha, Shiv
Calabresi, Peter A
and
Newsome, Scott D
2019.
Characteristics of morphologic macular abnormalities in neuroimmunology practice.
Multiple Sclerosis Journal,
Vol. 25,
Issue. 3,
p.
361.
De Angelis, Floriana
Connick, Peter
Parker, Richard A
Plantone, Domenico
Doshi, Anisha
John, Nevin
Stutters, Jonathan
MacManus, David
Prados, Ferran
Marshall, Ian
Solanky, Bhavana
Samson, Rebecca S
Barkhof, Frederik
Ourselin, Sebastien
Braisher, Marie
Ross, Moira
Cranswick, Gina
Pavitt, Sue H
Gnanapavan, Sharmilee
Giovannoni, Gavin
Wheeler-Kingshott, Claudia AM Gandini
Hawkins, Clive
Sharrack, Basil
Bastow, Roger
Weir, Christopher J
Stallard, Nigel
Chandran, Siddharthan
and
Chataway, Jeremy
2020.
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT.
Efficacy and Mechanism Evaluation,
Vol. 7,
Issue. 3,
p.
1.